Literature DB >> 7904606

Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma.

S Koyama1, K Fukao.   

Abstract

The causes of down-regulation of cytotoxic immune responses in cancer patients have not been fully evaluated. We previously demonstrated that T-cell-growth-factor-activated peripheral blood lymphocytes (PBL) with the surface phenotype CD8+ CD11b-, from patients with widespread metastasis of gastric carcinoma, inhibited the effector process of lymphokine-activated-killer(LAK)-cell-mediated cytolysis. In this study, we examined suppressor cell activity in freshly prepared PBL from 18 patients with advanced gastric carcinoma, and 10 normal healthy individuals. The suppressor cell activity was assayed by recording whether or not PBL inhibited directly the effector process of LAK cell cytotoxicity. Most of the PBL suspensions from cancer patients showed that they contained a population of cells that can directly inhibit the effector phase of tumor cell lysis of the cytotoxic cells. To analyze further the PBL responsible for the suppression, the cells were passed over a nylon-wool column. Nylon-wool-adherent cells significantly augmented the suppression, while the cells passing through abrogated the suppressive effect. Most nylon-wool-adherent cells from 10 normal healthy controls did not inhibit the cytotoxic reaction. To determine further the suppressor-effector population in nylon-wool-adherent cells, negative-selection studies using CD8-, CD4- or CD11b-coated magnetic beads, and positive-selection studies using CD8- or CD4-coated magnetic beads were performed. Finally the results suggest that the suppressor-effector cells comprise at least two different surface phenotypes: CD8+ T and CD8-CD11b+ cells. The possible role of CD4+ T cells and HLA-DR+ LeuM3+ macrophages as suppressor cells was ruled out in nylon-wool-adherent cells. CD8+ T and possibly CD8-CD11b+ cells apparently suppressed the efferent limb of the antitumor immunity. The selective immune suppression mediated by these cells may partly be concerned with escape mechanisms of gastric carcinoma from the host immune surveillance system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904606     DOI: 10.1007/bf01372563

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.

Authors:  T Ebihara; S Koyama
Journal:  Tohoku J Exp Med       Date:  1990-09       Impact factor: 1.848

2.  Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.

Authors:  B Mukherji; S A Wilhelm; A Guha; M T Ergin
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

3.  Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse.

Authors:  S Fujimoto; T Matsuzawa; K Nakagawa; T Tada
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation.

Authors:  L T Clement; C E Grossi; G L Gartland
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

6.  The generation of interleukin-2-dependent suppressor T-cells from patients with systemic metastasis of gastric carcinoma and the phenotypic characterization of the cells defined by monoclonal antibodies.

Authors:  S Koyama; K Fukao; S Fujimoto
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

7.  Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man.

Authors:  G S Kansas; E G Engleman
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

8.  Escape mechanisms of melanoma from immune system by soluble melanoma antigen.

Authors:  K Takahashi; K Ono; Y Hirabayashi; M Taniguchi
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Suppression by sorted CD8+CD11b- cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma.

Authors:  T Ebihara; N Sakai; S Koyama
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

10.  Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.

Authors:  Y Harada; M Sakatsume; G A Nores; S Hakomori; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1989-10
View more
  5 in total

1.  Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma.

Authors:  S Koyama
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels.

Authors:  K Wiers; M A Wright; K Vellody; M R Young
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

3.  Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma.

Authors:  Ning Zheng; Sheng-Long Ye; Rui-Xia Sun; Yan Zhao; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Immunosuppressive effect of shedding intercellular adhesion molecule 1 antigen on cell-mediated cytotoxicity against tumor cells.

Authors:  S Koyama
Journal:  Jpn J Cancer Res       Date:  1994-02

5.  Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.

Authors:  K Takahashi; S Sone; S Saito; Y Kamamura; T Uyama; T Ogura; Y Monden
Journal:  Jpn J Cancer Res       Date:  1995-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.